Myeloma DNA vaccine (Genvax)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMyeloma DNA vaccine (Genvax)
Drug Alias NameMyeloma vaccine (idiotypic) - Genvax
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGenvax
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGenvax
Active IndicationsN/A
Inactive IndicationsMultiple Myeloma

Other Information

ATC CodeN/A
Related LinksN/A